Integer Corporation (ITGR)
117.53
-0.54 (-0.46%)
At close: Mar 27, 2025, 3:59 PM
117.90
0.31%
Pre-market: Mar 28, 2025, 06:39 AM EDT
Integer Corporation Revenue Breakdown
Quarter | Dec 31, 2024 | Sep 27, 2024 | Sep 30, 2016 | Jul 1, 2016 | Apr 1, 2016 |
---|---|---|---|---|---|
Cardio And Vascular Revenue | 708.57M | 241.01M | 148.27M | 144.22M | 133.65M |
Cardio And Vascular Revenue Growth | +194.00% | +62.54% | +2.81% | +7.91% | n/a |
Revenue by Geography
Quarter | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 28, 2018 | Dec 29, 2017 | Dec 30, 2016 | Jan 1, 2016 | Jan 2, 2015 | Jan 3, 2014 | Dec 28, 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Puerto Rico Revenue | 137.06M | 108.42M | 114.08M | 110.16M | 96.05M | 154.64M | 146.5M | 133.75M | 159.24M | 136.9M | 127.7M | 117.96M | 105.73M |
Puerto Rico Revenue Growth | +26.41% | -4.96% | +3.55% | +14.69% | -37.89% | +5.56% | +9.53% | -16.01% | +16.32% | +7.20% | +8.26% | +11.57% | n/a |
Rest Of World Revenue | 516.17M | 501.25M | 423.74M | 372.44M | 321.74M | 341.34M | 319.21M | 465.88M | 352.64M | 199.59M | 182.24M | 113.77M | 107.93M |
Rest Of World Revenue Growth | +2.98% | +18.29% | +13.78% | +15.76% | -5.74% | +6.93% | -31.48% | +32.11% | +76.68% | +9.52% | +60.19% | +5.41% | n/a |
United States Revenue | 938.67M | 897.43M | 762.13M | 671.5M | 596.8M | 698.47M | 687.26M | 862.29M | 805.74M | 401.38M | 312.54M | 325.09M | n/a |
United States Revenue Growth | +4.60% | +17.75% | +13.50% | +12.52% | -14.56% | +1.63% | -20.30% | +7.02% | +100.74% | +28.43% | -3.86% | n/a | n/a |
Operating Expense Breakdown
Quarter | Dec 31, 2024 | Sep 27, 2024 | Jun 28, 2024 | Mar 29, 2024 | Dec 31, 2023 | Sep 29, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jul 1, 2022 | Apr 1, 2022 | Dec 31, 2021 | Oct 1, 2021 | Jul 2, 2021 | Apr 2, 2021 | Dec 31, 2020 | Oct 2, 2020 | Jul 3, 2020 | Apr 3, 2020 | Dec 31, 2019 | Sep 27, 2019 | Jun 28, 2019 | Mar 29, 2019 | Dec 28, 2018 | Sep 28, 2018 | Jun 29, 2018 | Mar 30, 2018 | Dec 29, 2017 | Sep 29, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 30, 2016 | Sep 30, 2016 | Jul 1, 2016 | Apr 1, 2016 | Jan 1, 2016 | Oct 2, 2015 | Jul 3, 2015 | Apr 3, 2015 | Jan 2, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 47.47M | 33.85M | 37.13M | 37.84M | 45.8M | 42.1M | 45.83M | 41.89M | 41.04M | 38.2M | 41.79M | 39.56M | 36.27M | 34.27M | 35.38M | 35.5M | 35.04M | 3.61M | 33.9M | 36.46M | 37.66M | 32.94M | 33.14M | 34.96M | 35.14M | 34.09M | 36.78M | 41.24M | 42.62M | 39.73M | 39.72M | 39.5M | 37.51M | 36.27M | 37.63M | 41.89M | 33.51M | 22.31M | 24.1M | 22.61M | 24.85M |
Selling, General, and Administrative Revenue Growth | +40.21% | -8.81% | -1.89% | -17.38% | +8.79% | -8.13% | +9.41% | +2.07% | +7.44% | -8.59% | +5.63% | +9.08% | +5.83% | -3.14% | -0.35% | +1.33% | +870.82% | -89.35% | -7.01% | -3.20% | +14.35% | -0.63% | -5.19% | -0.53% | +3.08% | -7.31% | -10.81% | -3.24% | +7.26% | +0.02% | +0.57% | +5.30% | +3.43% | -3.62% | -10.17% | +25.01% | +50.21% | -7.45% | +6.61% | -9.01% | n/a |
Research and Development Revenue | 10.61M | 11.92M | 16.1M | 15.75M | 13.26M | 14.54M | 16.88M | 19.09M | 13.84M | 16.12M | 14.87M | 16.08M | 12.74M | 12.05M | 13.74M | 13.46M | 10.59M | 11.89M | 12.75M | 13.24M | 11.81M | 11.73M | 11.4M | 11.6M | 10.16M | 12.23M | 12.94M | 14.54M | 15.34M | 13.61M | 12.89M | 13.41M | 12.64M | 11.41M | 13.64M | 17.31M | 13.09M | 14.3M | 13.06M | 12.54M | 9.88M |
Research and Development Revenue Growth | -10.98% | -25.96% | +2.23% | +18.83% | -8.82% | -13.88% | -11.57% | +37.94% | -14.15% | +8.42% | -7.54% | +26.28% | +5.69% | -12.29% | +2.06% | +27.12% | -10.96% | -6.70% | -3.74% | +12.13% | +0.68% | +2.92% | -1.72% | +14.14% | -16.96% | -5.42% | -11.03% | -5.23% | +12.74% | +5.57% | -3.89% | +6.07% | +10.79% | -16.33% | -21.18% | +32.23% | -8.47% | +9.46% | +4.13% | +26.94% | n/a |